SynthesisJournal of comparative effectiveness research2023

Indirect treatment comparison of lurbinectedin versus other second-line treatments for small-cell lung cancer.

Raj Hanvesakul et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.